Position
Fidelity in Dexcom Inc
Back to the book · All holders of DXCM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $21.7M$7.63 → $9.03
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 15.1M | $98.8M | — | — | — | 0.0% |
| Q1 2026 | 15.4M | $117.7M | $7.63 | $16M | $2.86M | 0.0% |
| Q2 2026 | 15.5M | $140.2M | $9.03 | $21.7M | $769.8K | 0.0% |